Form 8-K · Current report
CME Group 8-K, filed Oct 21, 2026
- Filed
- CIK
- 0001156375
- Accession no.
- 0001156375-26-000065
Summary
CME reported third-quarter 2026 revenue of $1.7 billion, operating income of $1.1 billion, net income of $1.0 billion and diluted earnings per share of $2.89, with adjusted diluted EPS of $3.02. Chairman and CEO Terry Duffy said clients turned to CME in record numbers as uncertainty intensified, with average daily volume reaching a Q3 record 29.4 million contracts and market data revenue at a record $243 million.
Key points
- Q3 2026 revenue was $1.7 billion, operating income $1.1 billion, net income $1.0 billion, and diluted EPS $2.89; adjusted operating income was $1.2 billion, adjusted net income $1.1 billion, and adjusted diluted EPS $3.02.
- Average daily volume rose to a third-quarter record 29.4 million contracts, with non-U.S. ADV at a Q3 high of 9 million contracts and double-digit volume growth across all six asset classes.
- Clearing and transaction fees revenue was $1.4 billion, the average rate per contract was $0.679, and market data revenue reached a record $243 million, up 20%.
- CME returned nearly $1 billion to shareholders through $465 million in dividends and $524 million in share repurchases, and had $2.4 billion in cash and $3.4 billion in debt as of September 30, 2026.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Condition. The information set forth under “Item 2.02. Results Of Operations and Financial Condition,” including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. Attached and incorporated herein by reference as Exhibit 99.1 is a copy of a press release of CME Group Inc. dated October 21, 2026, reporting CME Group Inc.’s financial results for the quarter ended September 30, 2026. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.